Former Practice Fusion CEO’s second act is going to market, backed by major life insurers
June 07, 2018 at 08:58 AM EDT
The San Francisco-based company sells a smartwatch launching in July that monitors biomarkers like a user’s heart rate, pulse strength, temperature, blood flow, oxygen levels to look for signals indicating a life-threatening cardiac episode and automatically alert emergency authorities.